Technology | May 17, 2013

MiE's PET Scintron Receives FDA Approval

ECAT Scintron offers upgrade path for longer life cycle of dedicated PET systems

May 17, 2013 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) ECAT Scintron. It is the only upgrade path available to the Siemens ECAT 47, ECAT HR+, and ECAT Accel positron emission tomography (PET) systems. The ACSII and SUN workstation are removed from the system and replaced with new PC-based technology that provides new and existing users of the ECAT series PET systems access to faster processing speeds, new acquisition protocols and parts availability. With improved reliability and longevity, the ECAT Scintron redefines the life cycle of dedicated PET systems in the U.S. market.

The Scintron unit is always a part of a MiE system and can also be upgraded to any existing system. It takes on all processes of the scanner — data acquiring, processing, viewing as well as gantry controlling, calibrating and servicing. 

For more information: www.mieamerica.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Overlay Init